NBIX vs TBBK · P/E 45, rev $1.77B vs P/E 11, rev $261.8M
Neurocrine Biosciences Inc (NBIX) versus The Bancorp Inc (TBBK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
The Bancorp Inc (TBBK) is a banks - regional company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported TBBK revenue for 2026-06-30 was $261.8M. Net income was $120.7M. TBBK currently screens at market cap $2.30B and trailing P/E 10.8.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. TBBK currently screens at market cap $2.30B and trailing P/E 10.8.
Not investment advice. Open the NBIX and TBBK stock pages for the full models.
Not investment advice.